Requirement for the SnoN Oncoprotein in Transforming Growth Factor β-Induced Oncogenic Transformation of Fibroblast Cells

REFERENCES

• Attisano, L., and J. L. Wrana. 2002. Signal transduction by the TGF-β superfamily. Science 296:1646–1647.
   PubMed Web of Science ®Google Scholar
• Barnard, J. A., R. M. Lyons, and H. L. Moses. 1990. The cell biology of transforming growth factor β. Biochim. Biophys. Acta 1032:79–87.
   PubMed Web of Science ®Google Scholar
• Bonni, S., H. R. Wang, C. G. Causing, P. Kavsak, S. L. Stroschein, K. Luo, and J. L. Wrana. 2001. TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat. Cell Biol. 3:587–595.
   PubMed Web of Science ®Google Scholar
• Boyd, K. E., and P. J. Farnham. 1999. Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol. Cell. Biol. 19:8393–8399.
   PubMed Web of Science ®Google Scholar
• Boyer, P. L., C. Colmenares, E. Stavnezer, and S. H. Hughes. 1993. Sequence and biological activity of chicken snoN cDNA clones. Oncogene 8:457–466.
   PubMedGoogle Scholar
• Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
   PubMed Web of Science ®Google Scholar
• Callahan, J. F., J. L. Burgess, J. A. Fornwald, L. M. Gaster, J. D. Harling, F. P. Harrington, J. Heer, C. Kwon, R. Lehr, A. Mathur, B. A. Olson, J. Weinstock, and N. J. Laping. 2002. Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5). J. Med. Chem. 45:999–1001.
   PubMed Web of Science ®Google Scholar
• Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091–3100.
   PubMed Web of Science ®Google Scholar
• Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29:117–129.
   PubMed Web of Science ®Google Scholar
• Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425:577–584.
   PubMed Web of Science ®Google Scholar
• Dunn, N. R., C. H. Koonce, D. C. Anderson, A. Islam, E. K. Bikoff, and E. J. Robertson. 2005. Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. Genes Dev. 19:152–163.
   PubMedGoogle Scholar
• Feinberg, M. W., M. K. Jain, F. Werner, N. E. Sibinga, P. Wiesel, H. Wang, J. N. Topper, M. A. Perrella, and M. E. Lee. 2000. Transforming growth factor-β1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J. Biol. Chem. 275:25766–25773.
   PubMed Web of Science ®Google Scholar
• Feng, X. H., Y. Y. Liang, M. Liang, W. Zhai, and X. Lin. 2002. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15(Ink4B). Mol. Cell 9:133–143.
   PubMed Web of Science ®Google Scholar
• Frederick, J. P., N. T. Liberati, D. S. Waddell, Y. Shi, and X. F. Wang. 2004. Transforming growth factor β-mediated transcriptional repression of c-Myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 24:2546–2559.
   PubMed Web of Science ®Google Scholar
• Germain, S., M. Howell, G. M. Esslemont, and C. S. Hill. 2000. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14:435–451.
   PubMed Web of Science ®Google Scholar
• He, J., S. B. Tegen, A. R. Krawitz, G. S. Martin, and K. Luo. 2003. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J. Biol. Chem. 278:30540–30547.
   PubMedGoogle Scholar
• Heldin, C.-H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471.
   PubMed Web of Science ®Google Scholar
• Imoto, I., A. Pimkhaokham, Y. Fukuda, Z. Q. Yang, Y. Shimada, N. Nomura, H. Hirai, M. Imamura, and J. Inazawa. 2001. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem. Biophys. Res. Commun. 286:559–565.
   PubMedGoogle Scholar
• Inman, G. J., F. J. Nicolas, J. F. Callahan, J. D. Harling, L. M. Gaster, A. D. Reith, N. J. Laping, and C. S. Hill. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:65–74.
   PubMed Web of Science ®Google Scholar
• Labbe, E., C. Silvestri, P. A. Hoodless, J. L. Wrana, and L. Attisano. 1998. Smad2 and Smad3 positively and negatively regulate TGF-β-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2:109–120.
   PubMed Web of Science ®Google Scholar
• Laping, N. J., E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan, and B. A. Olson. 2002. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62:58–64.
   PubMed Web of Science ®Google Scholar
• Liu, D., B. L. Black, and R. Derynck. 2001. TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15:2950–2966.
   PubMed Web of Science ®Google Scholar
• Liu, D., J. S. Kang, and R. Derynck. 2004. TGF-β-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J. 23:1557–1566.
   Google Scholar
• Liu, X., Y. Sun, R. A. Weinberg, and H. F. Lodish. 2001. Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev. 12:1–8.
   PubMedGoogle Scholar
• Luo, K. 2004. Ski and SnoN: negative regulators of TGF-β signaling. Curr. Opin. Genet. Dev. 14:65–70.
   PubMed Web of Science ®Google Scholar
• Luo, K., S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, and Q. Zhou. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:2196–2206.
   PubMed Web of Science ®Google Scholar
• Massague, J., and D. Wotton. 2000. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:1745–1754.
   PubMed Web of Science ®Google Scholar
• Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
   PubMedGoogle Scholar
• Moses, H. L., E. L. Branum, J. A. Proper, and R. A. Robinson. 1981. Transforming growth factor production by chemically transformed cells. Cancer Res. 41:2842–2848.
   PubMed Web of Science ®Google Scholar
• Moustakas, A., and D. Kardassis. 1998. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733–6738.
   PubMed Web of Science ®Google Scholar
• Nagarajan, R. P., J. Liu, and Y. Chen. 1999. Smad3 inhibits transforming growth factor-β and activin signaling by competing with Smad4 for FAST-2 binding. J. Biol. Chem. 274:31229–31235.
   PubMedGoogle Scholar
• Nicolas, F. J., and C. S. Hill. 2003. Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene 22:3698–3711.
   PubMed Web of Science ®Google Scholar
• Nomura, N., S. Sasamoto, S. Ishii, T. Date, M. Matsui, and R. Ishizaki. 1989. Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res. 17:5489–5500.
   PubMedGoogle Scholar
• Pearson-White, S. 1993. SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res. 21:4632–4638.
   PubMed Web of Science ®Google Scholar
• Pearson-White, S., and R. Crittenden. 1997. Proto-oncogene Sno expression, alternative isoforms and immediate early serum response. Nucleic Acids Res. 25:2930–2937.
   PubMed Web of Science ®Google Scholar
• Pelzer, T., G. E. Lyons, S. Kim, and R. W. Moreadith. 1996. Cloning and characterization of the murine homolog of the sno proto-oncogene reveals a novel splice variant. Dev. Dyn. 205:114–125.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., L. C. Lamb, D. L. Newton, M. B. Sporn, J. E. De Larco, and G. J. Todaro. 1980. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci. USA 77:3494–3498.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and L. M. Wakefield. 2003. The two faces of transforming growth factor β in carcinogenesis. Proc. Natl. Acad. Sci. USA 100:8621–8623.
   PubMed Web of Science ®Google Scholar
• Schutte, M., R. H. Hruban, L. Hedrick, K. R. Cho, G. M. Nadasdy, C. L. Weinstein, G. S. Bova, W. B. Isaacs, P. Cairns, H. Nawroz, D. Sidransky, R. A. Casero, Jr., P. S. Meltzer, S. A. Hahn, and S. E. Kern. 1996. DPC4 gene in various tumor types. Cancer Res. 56:2527–2530.
   PubMed Web of Science ®Google Scholar
• Shi, Y., A. Hata, R. S. Lo, J. Massague, and N. P. Pavletich. 1997. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388:87–93.
   PubMed Web of Science ®Google Scholar
• Shi, Y., and J. Massague. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700.
   PubMed Web of Science ®Google Scholar
• Shi, Y., Y. F. Wang, L. Jayaraman, H. Yang, J. Massague, and N. P. Pavletich. 1998. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 94:585–594.
   PubMed Web of Science ®Google Scholar
• Siegel, P. M., and J. Massague. 2003. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3:807–821.
   PubMed Web of Science ®Google Scholar
• Song, C.-Z., T. E. Siok, and T. D. Gelehrter. 1998. Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem. 273:29287–29290.
   PubMedGoogle Scholar
• Stroschein, S. L., S. Bonni, J. L. Wrana, and K. Luo. 2001. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev. 15:2822–2836.
   PubMed Web of Science ®Google Scholar
• Stroschein, S. L., W. Wang, and K. Luo. 1999. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced Smad-dependent transcriptional activation. J. Biol. Chem. 274:9431–9441.
   PubMedGoogle Scholar
• Stroschein, S. L., W. Wang, S. Zhou, Q. Zhou, and K. Luo. 1999. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286:771–774.
   PubMed Web of Science ®Google Scholar
• Sun, Y., X. Liu, E. Ng-Eaton, H. F. Lodish, and R. A. Weinberg. 1999. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc. Natl. Acad. Sci. USA 96:12442–12447.
   PubMed Web of Science ®Google Scholar
• ten Dijke, P., and C. S. Hill. 2004. New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 29:265–273.
   PubMed Web of Science ®Google Scholar
• Thiagalingam, S., C. Lengauer, F. S. Leach, M. Schutte, S. A. Hahn, J. Overhauser, J. K. Willson, S. Markowitz, S. R. Hamilton, S. E. Kern, K. W. Kinzler, and B. Vogelstein. 1996. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 13:343–346.
   PubMed Web of Science ®Google Scholar
• Tucker, R. F., G. D. Shipley, H. L. Moses, and R. W. Holley. 1984. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science 226:705–707.
   PubMed Web of Science ®Google Scholar
• Werner, F., M. K. Jain, M. W. Feinberg, N. E. Sibinga, A. Pellacani, P. Wiesel, M. T. Chin, J. N. Topper, M. A. Perrella, and M. E. Lee. 2000. Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3. J. Biol. Chem. 275:36653–36658.
   PubMed Web of Science ®Google Scholar
• Wilkes, M. C., S. J. Murphy, N. Garamszegi, and E. B. Leof. 2003. Cell-type-specific activation of PAK2 by transforming growth factor β independent of Smad2 and Smad3. Mol. Cell. Biol. 23:8878–8889.
   PubMed Web of Science ®Google Scholar
• Wu, J. W., A. R. Krawitz, J. Chai, W. Li, F. Zhang, K. Luo, and Y. Shi. 2002. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling. Cell 111:357–367.
   PubMed Web of Science ®Google Scholar
• Yagi, K., D. Goto, T. Hamamoto, S. Takenoshita, M. Kato, and K. Miyazono. 1999. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274:703–709.
   PubMedGoogle Scholar
• Zhang, F., M. Lundin, A. Ristimaki, P. Heikkila, J. Lundin, J. Isola, H. Joensuu, and M. Laiho. 2003. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-β signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res. 63:5005–5010.
   PubMedGoogle Scholar